Private company

ACTAVIA LIFE SCIENCES, INC.

ACTAVIA LIFE SCIENCES, INC. is an American pharmaceutical preparations company, incorporated in Nevada.¹ It is headquartered in New York, New York.¹

Last updated Oct 21, 2026.

Overview

IndustryPharmaceutical Preparations¹
HeadquartersNew York, New York¹
Incorporated inNV²
Business address5 Penn Plaza, 19Th Floor, #1954, New York, Ny 10001²
Filer categoryNon-accelerated filer, Smaller reporting company²

See how the biggest companies compare on our leaderboards

(Oryzon/Roche). RASP-201 when dosed orally shows in vivo therapeutic utility in murine (mouse) models of AML.³ From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2018

-131.3%Return on equity⁴

-$2.6MFree cash flow⁵

Financial statements

Revenue⁶⁷$0 in 2018

Gross profit⁷$0 in 2018

Operating income⁷⁵-$4.1M in 2018−10% since 2017

Net income⁷⁵-$4.1M in 2018−8% since 2017

Fiscal year	2017	2018
Revenue	$0⁶	$0⁷
Cost of revenue	$0⁷	$0⁷
Gross profit	$0⁷	$0⁷
Research and development	$1.6M⁷	$324.6K⁵
Operating expenses
Operating income	-$4.5M⁷	-$4.1M⁵
Interest		$2.3K⁵
Income tax	$0⁷	$2.1K⁵
Net income	-$4.4M⁷	-$4.1M⁵
Earnings per share
Earnings per share (diluted)
Shares (weighted, basic)
Shares (weighted, diluted)

Total assets⁷⁵$5.2M in 2018−31% since 2017

Total liabilities⁷⁵$2.1M in 2018+38% since 2017

Shareholders’ equity⁵⁴$3.1M in 2018−49% since 2017

Cash⁵⁴$42.7K in 2018−98% since 2017

Fiscal year	2017	2018
Cash	$2.5M⁵	$42.7K⁴
Current assets	$2.7M⁷	$347.5K⁵
Total assets	$7.6M⁷	$5.2M⁵
Accounts payable
Current liabilities	$1.5M⁷	$2.1M⁵
Total liabilities	$1.5M⁷	$2.1M⁵
Retained earnings
Shareholders’ equity	$6.0M⁵	$3.1M⁴
Shares outstanding	68.6M shares⁷	68.9M shares⁷

Cash from operations⁷⁵-$2.6M in 2018−11% since 2017

Capital spending⁷⁵$4.1K in 2018−61% since 2017

Free cash flow⁷⁵-$2.6M in 2018−11% since 2017

Fiscal year	2017	2018
Cash from operations	-$3.0M⁷	-$2.6M⁵
Stock-based compensation
Capital spending	$10.5K⁷	$4.1K⁵
Free cash flow	-$3.0M	-$2.6M
Cash from financing

Compare ACTAVIA LIFE SCIENCES, INC. with another company

Former names

Rasna Therapeutics Inc.Sep 27, 2016 to Aug 14, 2023²
Active With Me Inc.Sep 11, 2013 to Sep 26, 2016²

Timeline

Apr 10, 20248-K Change of auditor¹⁰
Oct 26, 20238-K Bylaws or fiscal year changed¹¹
Jan 23, 20238-K Bylaws or fiscal year changed¹²
Dec 20, 20228-K Bylaws or fiscal year changed¹³
May 24, 20228-K Unregistered sale of shares¹⁴
May 19, 20228-K Unregistered sale of shares¹⁵
May 9, 20228-K Earlier financial statements no longer reliable¹⁶
Nov 30, 20218-K Change of auditor¹⁷

Filings

29 filings to the SEC since October 2021: 4 annual reports, 8 quarterly reports, 8 major events, 9 other. The latest 20:

Aug 15, 2024NT 10-Q NOTIFICATION OF LATE FILING EDGAR
May 20, 202410-Q QUARTERLY REPORT EDGAR
May 15, 2024NT 10-Q EDGAR
Apr 10, 20248-K CURRENT REPORT EDGAR
Feb 16, 202410-Q QUARTERLY REPORT EDGAR
Feb 14, 2024NT 10-Q NOTIFICATION OF LATE FILING EDGAR
Jan 5, 202410-K ANNUAL REPORT EDGAR
Dec 29, 2023NT 10-K NOTIFICATION OF LATE FILING EDGAR
Oct 26, 20238-K CURRENT REPORT EDGAR
Aug 14, 202310-Q QUARTERLY REPORT EDGAR
May 15, 202310-Q QUARTERLY REPORT EDGAR
Mar 2, 202310-Q QUARTERLY REPORT EDGAR
Feb 9, 202310-K ANNUAL REPORT EDGAR
Jan 23, 20238-K CURRENT REPORT EDGAR
Dec 28, 2022NT 10-K NOTIFICATION OF LATE FILING EDGAR
Dec 20, 20228-K CURRENT REPORT EDGAR
Aug 22, 202210-Q QUARTERLY REPORT EDGAR
Aug 15, 2022NT 10-Q NOTIFICATION OF LATE FILING EDGAR
Jun 21, 202210-Q QUARTERLY REPORT EDGAR
Jun 16, 202210-Q QUARTERLY REPORT EDGAR

The 29 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

SEC filer profile

How ACTAVIA LIFE SCIENCES, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

Name on EDGARACTAVIA LIFE SCIENCES, INC.¹
CIK0001582249
Employer ID (EIN)39-2080103¹
Filer statusNon-accelerated filer<br>smaller reporting company¹
Incorporated inNevada¹
Fiscal year endsSeptember 30¹
Industry code (SIC)2834 Pharmaceutical Preparations¹
SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance¹
Business address5 Penn Plaza, 19Th Floor, #1954, New York, NY 10001¹
Phone646-396-4087¹
Shares outstanding771,811,360 as of May 20, 2024⁹
Public float$1.7M as of Mar 31, 2023¹⁸
On EDGAR sinceSep 11, 2013¹
Filings133 in all: 8-K (33), 10-Q (31), NT 10-Q (14), 10-K (10), CORRESP (10), UPLOAD (9), NT 10-K (7), EFFECT (4)¹
All 17 form types
10-Q/A (3), 10-K/A (2), 8-K/A (2), POS AM (2), S-1/A (2), 10-KT (1), D (1), S-1 (1), S-3 (1)
Latest filingsAnnual report (10-K) Jan 5, 2024
Quarterly report (10-Q) May 20, 2024
Latest 8-K (8-K) Apr 10, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARACTAVIA LIFE SCIENCES, INC. filings on SEC EDGAR
2
SEC EDGARACTAVIA LIFE SCIENCES, INC. filings on SEC EDGAR
3
SEC EDGARACTAVIA LIFE SCIENCES, INC. annual report, Item 1 (Business)
4
SEC EDGARACTAVIA LIFE SCIENCES, INC. 10-K for fiscal 2018
5
SEC EDGARACTAVIA LIFE SCIENCES, INC. 10-K for fiscal 2018
6
SEC EDGARACTAVIA LIFE SCIENCES, INC. 10-K for fiscal 2017
7
SEC EDGARACTAVIA LIFE SCIENCES, INC. 10-K for fiscal 2018
8
SEC EDGARACTAVIA LIFE SCIENCES, INC. 10-Q for fiscal 2023
9
SEC EDGARACTAVIA LIFE SCIENCES, INC. 10-Q for fiscal 2024
10
SEC EDGARChange of auditor
11
SEC EDGARBylaws or fiscal year changed
12
SEC EDGARBylaws or fiscal year changed
13
SEC EDGARBylaws or fiscal year changed
14
SEC EDGARUnregistered sale of shares
15
SEC EDGARUnregistered sale of shares
16
SEC EDGAREarlier financial statements no longer reliable
17
SEC EDGARChange of auditor
18
SEC EDGARACTAVIA LIFE SCIENCES, INC. 10-K filed Jan 5, 2024: public float